LTR Pharma new access agreement with Mens Health Downunder to facilitate supply of SPONTAN has been featured in a Special Report in The Australian newspaper, highlighting the significant unmet need for fast-acting and effect treatments for Erectile Dysfunction.
“MHDU founder and executive chairman Brad Butt said the collaboration with LTR Pharma enhances its ability to provide innovative solutions for men’s health concerns.
“SPONTAN’s rapid-onset profile addresses a significant unmet need in erectile dysfunction treatment, complementing our multi-disciplinary and multi-modal approach to men’s healthcare,” he said.
LTR Pharma chairman Lee Rodne said the agreement with MHDU represented another significant milestone in SPONTAN’s commercialisation journey.
“By partnering with Australia’s largest men’s health pharmacy clinic, we continue to broaden access to SPONTAN while maintaining our commitment to patient care through qualified healthcare professionals,” he said.”